Use of in-vitro genotoxicity and cell transformation assays to evaluate the potential carcinogenicity of fibres.
Jaurand
M C
MC
INSERM Unité 139, Institut Mondor de Médecine Moléculaire (IM3), Faculté de Médecine, Créteil, France.
D000818:Animals; D015197:Carcinogenicity Tests; D002273:Carcinogens / Q000009:adverse effects*; D002455:Cell Division / Q000187:drug effects; D002471:Cell Transformation, Neoplastic / Q000473:pathology*; D002478:Cells, Cultured; D004249:DNA Damage; D005786:Gene Expression Regulation / Q000187:drug effects; D006801:Humans; D008903:Minerals / Q000009:adverse effects*; D008938:Mitosis / Q000187:drug effects; D009152:Mutagenicity Tests; D009153:Mutagens / Q000009:adverse effects*
D002273:Carcinogens; D008903:Minerals; D009153:Mutagens